Borroni, R.G. et al. 2021. Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study. Acta Dermato-Venereologica. 101, 11 (Nov. 2021), adv00605. DOI:https://doi.org/10.2340/actadv.v101.283.